CompletedPHASE2, PHASE3NCT01006629
Palivizumab for Prevention of Severe Respiratory Syncytial Virus Infection in Russian Children
Studying Bronchopulmonary dysplasia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Abbott
- Principal Investigator
- Konstantin M Gudkov, MD, MDAbbott
- Intervention
- palivizumab(biological)
- Enrollment
- 100 enrolled
- Eligibility
- 2 years · All sexes
- Timeline
- 2009 – 2010
Study locations (19)
- Site Ref # / Investigator 22699, Ivanovo, Russia
- Site Ref # / Investigator 22694, Kazan', Russia
- Site Ref # / Investigator 24022, Moscow, Russia
- Site Ref # / Investigator 15744, Moscow, Russia
- Site Ref # / Investigator 15745, Moscow, Russia
- Site Ref # / Investigator 24025, Moscow, Russia
- Site Ref # / Investigator 15781, Moscow, Russia
- Site Ref # / Investigator 22686, Moscow, Russia
- Site Ref # / Investigator 15747, Moscow, Russia
- Site Ref # / Investigator 22696, Novosibirsk, Russia
- Site Ref # / Investigator 24023, Novosibirsk, Russia
- Site Ref # / Investigator 22692, Saint Petersburg, Russia
- Site Ref # / Investigator 22683, Saint Petersburg, Russia
- Site Ref # / Investigator 22693, Saint Petersburg, Russia
- Site Ref # / Investigator 22685, Saint Petersburg, Russia
- +4 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01006629 on ClinicalTrials.govOther trials for Bronchopulmonary dysplasia
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06373289Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm InfantsUniversity of Alabama at Birmingham
- RECRUITINGNCT07109791National Surveillance and Prevention of Neonatal VAPUniversity of Alberta
- RECRUITINGPHASE2NCT07561125Effects of IVIG for BPD in Preterm Infant Born at 28 Weeks and BelowInternational Peace Maternity and Child Health Hospital
- RECRUITINGPHASE2NCT06915441Lipid Infusions to Optimize Nutrition TrialThe University of Texas Health Science Center, Houston
- RECRUITINGPHASE1, PHASE2NCT07101640PK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With Developing Bronchopulmonary DysplasiaDuke University
- RECRUITINGNCT07273643Characterization of Extracellular Vesicles From the Cord Blood of Extremely Preterm New Borns and Their Correlation With Severe Morbidity and MortalityUniversity Hospital, Montpellier
- RECRUITINGEARLY PHASE1NCT07120971Metformin for Premature Infants With Bronchopulmonary DysplasiaMedical College of Wisconsin
- RECRUITINGPHASE1NCT06589245Inhaled Ciclesonide Study in Preterm InfantsVenkatesh Sampath